Skip to main content

Table 1 Effect on survival of TNF sensitive L929s cells following exposure to 300 U/ml human TNF and various test solutions of TNF blocking agents in the presence of 1 μg/ml Actinomycin D

From: 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study

 

Mean % cell survival (SD)

Tested TNF blockers at 3 concentrations

99mTc-S-HYNIC CZP

S-HYNIC CZP

CZP

Infliximab

Control (no TNF blocker)

0.0 (0.0)

0.0 (0.0)

0.0 (0.0)

0.0 (0.0)

250 ng/ml

109.1 (2.6)

111.9 (0.5)

81.8 (1.5)

81.1 (3.9)

50 ng/ml

113.8 (4.2)

111.0 (2.2)

96.1 (23.2)

57.4 (1.4)

10 ng/ml

115.2 (0.6)

88.5 (0.3)

56.6 (2.8)

5.2 (0.0)